Form 4: Vaxcyte Executive Sells Shares
Insider Transaction (Form 4)
Harpreet S. Dhaliwal, Chief Technical Ops Officer of Vaxcyte, Inc., sold 17,000 shares of common stock on August 5, 2026 for $55.00 per share.
Summary
- Option exercise/conversion: acquired 17,000 Common Stock at $24.79 ($421,430) on August 5, 2026; holds 93,756 after (Direct).
- Open-market sale: disposed of 17,000 Common Stock at $55.00 ($935,068) on August 5, 2026; holds 76,756 after (Direct).
- Option exercise/conversion: disposed of 17,000 Stock Option (right to buy) on August 5, 2026; holds 28,000 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $935,068 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Harpreet S. Dhaliwal — Officer (Chief Technical Ops Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-05 | Option exercise/conversion | Common Stock | 17,000 | $25 | $421.4K | 93,756 |
| 2026-08-05 | Open-market sale | Common Stock | 17,000 | $55 | $935.1K | 76,756 |
| 2026-08-05 | Option exercise/conversion | Stock Option (right to buy) | 17,000 | — | — | 28,000 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-05 | Option exercise/conversion (17,000 shares) |
| 2026-08-05 | Open-market sale (17,000 shares) |
| 2026-08-05 | Option exercise/conversion (17,000 shares) |
Keywords
insider transaction, Form 4, PCVX, Vaxcyte, Inc., bearish, Harpreet S. Dhaliwal
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.